Annual Activities Report 2011 - INCT-Inofar - UFRJ
Annual Activities Report 2011 - INCT-Inofar - UFRJ
Annual Activities Report 2011 - INCT-Inofar - UFRJ
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Annual</strong> <strong>Report</strong> <strong>2011</strong> | <strong>INCT</strong>-INOFAR<br />
Highlights<br />
highly comparable to that of the positive control Temik. Moreover, in anthelmintic assays against the<br />
gastrointestinal parasitic nematode Nippostrongylus brasiliensis (L4), some of the compounds, such as<br />
(6-chloropyrazin-2-yl)sulfanyl ethanol (32, EC 50<br />
= 33 nM), presented activities that were considerably<br />
stronger than that of the positive control albendazole (EC 50<br />
= 340 nM).<br />
In the light of the positive results obtained in the anthelmintic evaluations, the acute oral toxicity of<br />
the representative compound diethyl 2,2’-[(3-nitropyridine-2,6-diyl) bissulfanediyl] diacetate (7) was<br />
determined in rats, and the drug was shown to be non-toxic at a dose of 2000 mg/kg. These results, allied<br />
with the relatively simple structures of the active compounds and their facile synthesis, highlight their<br />
potential use as anthelmintic or nematicidic agents.<br />
Scheme (1). Synthesis of compounds 7 - 33. Reagents and conditions: a) ethyl-2-mercaptoacetate,<br />
NaH, anhydrous THF, N 2<br />
atmosphere, room temperature or ice bath, depending on the reaction, for 5<br />
min to 12 h, depending on the starting material; b) NaOH, EtOH/H 2<br />
O (2:1), room temperature for<br />
1 h; c) alcohol (MeOH, n-PrOH or n-BuOH), H 2<br />
SO 4<br />
, reflux for 12 h; d) LiAlH 4<br />
, anhydrous THF, N 2<br />
atmosphere, ice bath for 12 h; e) Feo, NH 4<br />
Cl, EtOH/H 2<br />
O (2:1), reflux for 90 min.<br />
Table 1. In vitro AChE inhibitory, nematostatic and anthelmintic activities of the most active compounds.<br />
Compound<br />
AChE inhibition (LOD, M. Incognita N. brasiliensis death<br />
nmol)<br />
immobilization (%) (EC 50<br />
, nM)<br />
7 8.6 12 56.0<br />
10 - 19 34.0<br />
11 13.0 98 -<br />
17 - - 230.0<br />
18 - - -<br />
21 - - 60.0<br />
26 12.0 - 69.0<br />
32 130.0 - 33.0<br />
a<br />
physostigmine | b Temik | c albendazole<br />
55<br />
Patent<br />
LC Dias, AS Vieira, EJ Barreiro, Process for obtaining calcium atorvastatin using novel intermediates, PI<br />
018110015039 (INPI, in 04/25/<strong>2011</strong>), PCT in december, <strong>2011</strong>.